Loading insider details...
Latest Form 4 (Jun 17, 2026): Exercise/Conversion of 6,460 ABOS shares, $6.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Exercise/Conversion | 6,460 | $6.9K |
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| May 21, 2026 | Passage BIO, Inc. (PASG) | Grant/Award | 10,539 | n/a |
| Jun 5, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 12,800 | n/a |
| May 30, 2025 | Passage BIO, Inc. (PASG) | Grant/Award | 201,857 | n/a |
| Jun 10, 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| May 23, 2024 | Passage BIO, Inc. (PASG) | Grant/Award | 47,693 | n/a |
| Jun 7, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| May 26, 2023 | Passage BIO, Inc. (PASG) | Grant/Award | 24,000 | n/a |
| Jan 5, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 50,000 | n/a |